Rifampicin--a mild immunosuppressive agent for psoriasis

The Journal of Dermatological Treatment
Nikolai Tsankov, Ivan Grozdev

Abstract

The immunosuppressive properties of rifampicin have been discussed in the literature for more than 30 years. It is hypothesized that rifampicin acts as a mild immunosuppressive agent in psoriasis rather than an antibacterial one. We report our studies on the therapeutic efficacy of rifampicin in guttate psoriasis. We try to give light on the mechanism of action of rifampicin in psoriasis. Our therapeutic results together with data from the literature revealed rifampicin to be a mild immunosuppressive agent. Its best effectiveness is in the guttate type of the disease.

References

Aug 14, 1971·Lancet·B S Nilsson
Dec 1, 1993·Journal of the American Academy of Dermatology·N Tsankov, M Krasteva
Jun 1, 1993·International Journal of Dermatology·N K Tsankov, J A Kamarashev
Aug 31, 2004·Journal of Chemotherapy·H M ZiglamR G Finch
Feb 10, 2006·The Journal of Dermatological Treatment·Nikolai TsankovJana Kkzandjieva
Apr 4, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·N Tsankov, I Grozdev

❮ Previous
Next ❯

Citations

Dec 10, 2013·Biochimica Et Biophysica Acta·Matthias SchmuthSandrine Dubrac
Jul 19, 2012·The British Journal of Dermatology·J McFaddenI Kimber
Mar 6, 2019·The Cochrane Database of Systematic Reviews·Gwendy DupireLaurence Le Cleach
Apr 11, 2018·Rheumatology International·Döndü Üsküdar CansuCengiz Korkmaz
Aug 20, 2019·Archives of Dermatological Research·Patricia HispánJosé Carlos Pascual
Sep 10, 2019·Expert Review of Clinical Pharmacology·Ya-Chu Tsai, Tsen-Fang Tsai
Jun 17, 2021·Rheumatology International·Reşit YıldırımCengiz Korkmaz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Dermatology : International Journal for Clinical and Investigative Dermatology
E M de JongP C van De Kerkhof
Journal of the American Academy of Dermatology
Alison EhrlichAndrew Blauvelt
© 2021 Meta ULC. All rights reserved